Q3 2021 Recro Pharma Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Recro Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call may be recorded.
I would now like to hand the conference over to Stephanie Diaz of Recro's Investor Relations Group. Please go ahead.
Thank you. Hello, and thank you for joining us. On today's call, we have David Enloe, President and CEO; and Ryan Lake, Chief Financial Officer.
Today, we will be providing an overview of Recro's contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended September 30, 2021. After our prepared remarks, we will welcome your questions.
Before we begin, I'd like to caution that comments made during this conference call today, November 9, 2021, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, concerning the current beliefs of the company, which involve a number of assumptions, risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |